Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Title
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Authors
Keywords
-
Journal
LANCET
Volume 395, Issue 10234, Pages 1407-1409
Publisher
Elsevier BV
Online
2020-04-10
DOI
10.1016/s0140-6736(20)30858-8

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started